RDY Historical Balance Sheet

RDY Stock

USD 14.20 0.21 1.50%

Trend analysis of Dr Reddys Laboratories balance sheet accounts such as Retained Earnings of 279.2 B, Accounts Payable of 14.3 B, Cash of 13.6 B or Other Assets of 8.6 B provides information on Dr Reddys' total assets, liabilities, and equity, which is the actual value of Dr Reddys Laboratories to its prevalent stockholders. By breaking down trends over time using Dr Reddys balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Dr Reddys Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dr Reddys Laboratories is a good buy for the upcoming year.

Dr Reddys Inventory

31.96 Billion

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

About RDY Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Dr Reddys Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Dr Reddys Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Dr Reddys and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which RDY currently owns. An asset can also be divided into two categories, current and non-current.

Dr Reddys Balance Sheet Chart

At this time, Dr Reddys' Cash And Short Term Investments are fairly stable compared to the past year. Good Will is likely to rise to about 6.5 B in 2024, whereas Total Assets are likely to drop slightly above 214.9 B in 2024.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Dr Reddys assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dr Reddys Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Dr Reddys balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Dr Reddys Laboratories are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Dr Reddys' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Dr Reddys Laboratories current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	48.3B	53.5B	58.1B	61.0B
Total Assets	296.7B	322.9B	387.5B	214.9B

Other Current Liab Total Assets

Dr Reddys balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Short Term Investments	Inventory	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding
Total Assets		0.97	0.99	0.96	-0.06	0.99	0.54	-0.14	-0.14	0.91	1.0	0.99	0.91	0.98	-0.16	0.95	-0.2	0.99	-0.05	0.96	0.99	0.88	0.95	1.0	0.98	0.27
Other Current Liab	0.97		0.96	0.99	0.13	0.95	0.46	0.0	-0.18	0.95	0.98	0.94	0.88	0.93	-0.01	0.88	-0.14	0.95	0.07	0.9	0.96	0.93	0.97	0.97	0.96	0.33
Total Current Liabilities	0.99	0.96		0.94	-0.14	1.0	0.57	-0.18	-0.16	0.88	0.99	1.0	0.9	0.99	-0.22	0.98	-0.23	1.0	-0.11	0.97	0.99	0.85	0.93	0.99	0.99	0.24
Total Stockholder Equity	0.96	0.99	0.94		0.19	0.94	0.45	0.0	-0.15	0.97	0.96	0.93	0.87	0.91	0.04	0.86	-0.11	0.94	0.07	0.88	0.95	0.95	0.98	0.95	0.95	0.35
Retained Earnings	-0.06	0.13	-0.14	0.19		-0.15	-0.36	0.68	0.09	0.21	-0.03	-0.17	0.04	-0.22	0.87	-0.31	0.52	-0.14	0.7	-0.27	-0.07	0.22	0.13	-0.08	-0.12	0.41
Accounts Payable	0.99	0.95	1.0	0.94	-0.15		0.56	-0.23	-0.13	0.89	0.99	1.0	0.9	0.99	-0.24	0.98	-0.25	1.0	-0.16	0.98	0.99	0.87	0.93	0.99	0.99	0.23
Cash	0.54	0.46	0.57	0.45	-0.36	0.56		-0.45	-0.31	0.5	0.51	0.59	0.32	0.6	-0.49	0.63	-0.4	0.57	-0.38	0.49	0.52	0.36	0.54	0.56	0.57	0.43
Other Assets	-0.14	0.0	-0.18	0.0	0.68	-0.23	-0.45		0.12	-0.12	-0.1	-0.23	0.01	-0.27	0.8	-0.33	0.64	-0.2	0.85	-0.28	-0.13	-0.12	-0.13	-0.15	-0.2	0.2
Long Term Debt	-0.14	-0.18	-0.16	-0.15	0.09	-0.13	-0.31	0.12		-0.24	-0.15	-0.13	0.19	-0.16	0.4	-0.11	0.59	-0.13	0.07	-0.06	-0.08	-0.26	-0.24	-0.18	-0.15	0.1
Short Term Investments	0.91	0.95	0.88	0.97	0.21	0.89	0.5	-0.12	-0.24		0.91	0.88	0.77	0.87	-0.01	0.81	-0.2	0.89	-0.01	0.81	0.89	0.98	0.99	0.91	0.91	0.34
Inventory	1.0	0.98	0.99	0.96	-0.03	0.99	0.51	-0.1	-0.15	0.91		0.98	0.9	0.97	-0.14	0.94	-0.21	0.99	-0.01	0.95	0.99	0.88	0.95	0.99	0.98	0.26
Total Liab	0.99	0.94	1.0	0.93	-0.17	1.0	0.59	-0.23	-0.13	0.88	0.98		0.89	1.0	-0.26	0.99	-0.26	1.0	-0.16	0.98	0.99	0.84	0.92	0.99	0.99	0.24
Intangible Assets	0.91	0.88	0.9	0.87	0.04	0.9	0.32	0.01	0.19	0.77	0.9	0.89		0.86	0.08	0.86	0.15	0.9	0.03	0.9	0.94	0.75	0.8	0.89	0.88	0.31
Common Stock	0.98	0.93	0.99	0.91	-0.22	0.99	0.6	-0.27	-0.16	0.87	0.97	1.0	0.86		-0.31	0.99	-0.3	0.99	-0.21	0.98	0.98	0.84	0.92	0.98	0.99	0.23
Property Plant Equipment	-0.16	-0.01	-0.22	0.04	0.87	-0.24	-0.49	0.8	0.4	-0.01	-0.14	-0.26	0.08	-0.31		-0.37	0.85	-0.22	0.66	-0.31	-0.14	0.01	-0.07	-0.19	-0.22	0.29
Short Long Term Debt Total	0.95	0.88	0.98	0.86	-0.31	0.98	0.63	-0.33	-0.11	0.81	0.94	0.99	0.86	0.99	-0.37		-0.31	0.98	-0.27	0.99	0.96	0.77	0.86	0.96	0.97	0.19
Other Liab	-0.2	-0.14	-0.23	-0.11	0.52	-0.25	-0.4	0.64	0.59	-0.2	-0.21	-0.26	0.15	-0.3	0.85	-0.31		-0.23	0.39	-0.26	-0.15	-0.19	-0.24	-0.23	-0.24	0.24
Property Plant And Equipment Net	0.99	0.95	1.0	0.94	-0.14	1.0	0.57	-0.2	-0.13	0.89	0.99	1.0	0.9	0.99	-0.22	0.98	-0.23		-0.14	0.98	0.99	0.86	0.93	0.99	0.99	0.25
Current Deferred Revenue	-0.05	0.07	-0.11	0.07	0.7	-0.16	-0.38	0.85	0.07	-0.01	-0.01	-0.16	0.03	-0.21	0.66	-0.27	0.39	-0.14		-0.22	-0.07	-0.05	-0.03	-0.07	-0.13	0.19
Net Debt	0.96	0.9	0.97	0.88	-0.27	0.98	0.49	-0.28	-0.06	0.81	0.95	0.98	0.9	0.98	-0.31	0.99	-0.26	0.98	-0.22		0.97	0.8	0.86	0.96	0.97	0.14
Non Current Assets Total	0.99	0.96	0.99	0.95	-0.07	0.99	0.52	-0.13	-0.08	0.89	0.99	0.99	0.94	0.98	-0.14	0.96	-0.15	0.99	-0.07	0.97		0.86	0.93	0.99	0.99	0.27
Non Currrent Assets Other	0.88	0.93	0.85	0.95	0.22	0.87	0.36	-0.12	-0.26	0.98	0.88	0.84	0.75	0.84	0.01	0.77	-0.19	0.86	-0.05	0.8	0.86		0.96	0.87	0.88	0.22
Cash And Short Term Investments	0.95	0.97	0.93	0.98	0.13	0.93	0.54	-0.13	-0.24	0.99	0.95	0.92	0.8	0.92	-0.07	0.86	-0.24	0.93	-0.03	0.86	0.93	0.96		0.94	0.94	0.33
Net Receivables	1.0	0.97	0.99	0.95	-0.08	0.99	0.56	-0.15	-0.18	0.91	0.99	0.99	0.89	0.98	-0.19	0.96	-0.23	0.99	-0.07	0.96	0.99	0.87	0.94		0.99	0.27
Good Will	0.98	0.96	0.99	0.95	-0.12	0.99	0.57	-0.2	-0.15	0.91	0.98	0.99	0.88	0.99	-0.22	0.97	-0.24	0.99	-0.13	0.97	0.99	0.88	0.94	0.99		0.26
Common Stock Shares Outstanding	0.27	0.33	0.24	0.35	0.41	0.23	0.43	0.2	0.1	0.34	0.26	0.24	0.31	0.23	0.29	0.19	0.24	0.25	0.19	0.14	0.27	0.22	0.33	0.27	0.26

Click cells to compare fundamentals

Dr Reddys Account Relationship Matchups

Dr Reddys balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	232.2B	265.5B	296.7B	322.9B	387.5B	214.9B
Other Current Liab	39.4B	45.3B	48.3B	53.5B	58.1B	61.0B
Total Current Liabilities	72.8B	81.5B	97.8B	85.7B	96.0B	69.8B
Total Stockholder Equity	155.0B	175.0B	190.5B	232.9B	280.6B	294.6B
Retained Earnings	144.2B	157.9B	175.7B	215.6B	265.9B	279.2B
Accounts Payable	10.7B	12.7B	16.0B	17.9B	21.5B	14.3B
Cash	2.1B	14.8B	14.9B	5.8B	7.1B	13.6B
Other Assets	14.8B	11.6B	13.7B	7.1B	8.2B	8.6B
Long Term Debt	21.4B	0.0	6.3B	5.7B	3.8B	3.5B
Short Term Investments	23.7B	19.7B	29.5B	61.0B	74.4B	78.1B
Inventory	35.1B	45.4B	50.9B	48.7B	63.6B	32.0B
Total Liab	77.3B	90.5B	106.1B	90.0B	107.0B	89.6B
Intangible Assets	27.7B	35.6B	27.2B	30.7B	37.0B	24.7B
Property Plant Equipment	52.3B	57.1B	62.2B	66.3B	76.2B	80.1B
Short Long Term Debt Total	22.1B	30.3B	33.8B	13.5B	20.0B	19.0B
Other Liab	3.5B	3.1B	2.7B	2.5B	2.9B	3.1B
Property Plant And Equipment Net	52.3B	57.1B	62.2B	56.5B	76.9B	55.3B
Current Deferred Revenue	1.9B	2.0B	2.6B	2.0B	1.4B	1.4B
Net Debt	20.0B	15.5B	19.0B	7.7B	12.9B	12.3B
Non Current Assets Total	101.9B	117.2B	115.5B	118.6B	139.5B	98.4B
Non Currrent Assets Other	2.6B	952M	948M	12.7B	16.1B	16.9B
Cash And Short Term Investments	25.7B	34.6B	44.4B	66.7B	81.5B	85.5B
Net Receivables	61.8B	49.6B	66.8B	72.5B	80.3B	48.4B
Good Will	4.0B	4.6B	4.4B	5.5B	4.3B	6.5B
Common Stock Shares Outstanding	166.1M	166.3M	166.3M	166.4M	166.7M	175.5M
Liabilities And Stockholders Equity	232.2B	265.5B	296.7B	322.9B	387.5B	223.8B
Non Current Liabilities Total	4.4B	9.0B	8.3B	4.3B	10.9B	20.2B
Other Current Assets	5.8B	18.6B	19.8B	21.3B	22.7B	23.9B
Other Stockholder Equity	7.5B	8.2B	8.4B	10.3B	1.7B	1.6B
Total Current Assets	130.4B	148.2B	181.1B	204.3B	248.0B	127.1B
Accumulated Other Comprehensive Income	2.4B	1.3B	1.1B	1.3B	4.0B	3.8B
Short Term Debt	20.8B	24.0B	28.1B	12.2B	14.0B	27.0B
Property Plant And Equipment Gross	52.3B	57.1B	142.0B	152.3B	170.1B	161.6B
Net Tangible Assets	91.9B	123.3B	134.8B	158.9B	182.7B	102.9B
Long Term Investments	3.1B	8.3B	8.0B	6.1B	5.3B	4.6B
Short Long Term Debt	20.3B	24.0B	28.1B	12.2B	12.7B	16.6B
Long Term Debt Total	1.3B	6.3B	5.7B	1.3B	1.2B	1.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

RDY Historical Balance Sheet

Dr Reddys Inventory

31.96 Billion

About RDY Balance Sheet Analysis

Dr Reddys Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Dr Reddys balance sheet Correlations

Dr Reddys Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dr Reddys balance sheet Accounts

Also Currently Popular

Additional Tools for RDY Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Inventory	+ 1.0	Total Assets
Net Receivables	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Total Current Liabilities
Property Plant And Equipment Net	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Accounts Payable

Property Plant Equipment	- 0.49	Cash
Other Assets	- 0.45	Cash
Other Liab	- 0.4	Cash
Current Deferred Revenue	- 0.38	Cash
Short Long Term Debt Total	- 0.37	Property Plant Equipment
Cash	- 0.36	Retained Earnings